NCT07553273 Vibratory Anesthesia on Pain Following Corticosteroid Injections
| NCT ID | NCT07553273 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Texas Medical Branch, Galveston |
| Condition | Bilateral Arthritis of Wrist |
| Study Type | INTERVENTIONAL |
| Enrollment | 165 participants |
| Start Date | 2026-04 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 165 participants in total. It began in 2026-04 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research study aims to evaluate injectional pain at the site of needle insertion for corticosteroid injections (CSI) of the upper extremity depending on different modes of anesthetics. Each individual's perception of pain upon receiving a CSI with two out of three modes of anesthesia (control/no anesthesia, vibrational anesthesia, vapo-coolant anesthesia) will be utilized to compare these variables and determine the method that is associated with the least pain.
Eligibility Criteria
Inclusion Criteria: * Any patient of the Principal Investigator who has clinically diagnosed bilateral arthritis, tendinopathy, arthropathy, or compression neuropathy of the hand, wrist, or elbow where treatment with corticosteroid injection is indicated. * Participants who voluntarily consent to participate in the study and sign consent forms. * Participants who complete all numeric pain rating scales * Patients aged ≥ 18 years old Exclusion Criteria: * Participants who opt out of the study or withdraw consent * Participants who are determined to be without capacity to consent to study participation or injection procedure by principal investigator * Participants with inability to complete numeric pain rating scales * Participants with known allergies to triamcinolone acetonide, lidocaine, or bupivicaine * Participants without clinically diagnosed bilateral arthritis, tendinopathy, arthropathy, or compression neuropathy of the hand, wrist, or elbow. * Participants where treatment with corticosteroid injection is not indicated bilaterally. * Patients ≤ 18 years old
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07553273 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bilateral Arthritis of Wrist. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07553273 currently recruiting?
Yes, NCT07553273 is actively recruiting participants. Contact the research team at jofailla@utmb.edu for enrollment information.
Where is the NCT07553273 trial being conducted?
This trial is being conducted at Galveston, United States.
Who is sponsoring the NCT07553273 clinical trial?
NCT07553273 is sponsored by The University of Texas Medical Branch, Galveston. The trial plans to enroll 165 participants.